FEDERAL · 21 CFR

§ 201.1-201 — Not Yet Available

21 C.F.R. § 201.1-201

21 C.F.R. § 201.1-201 is referenced in other legal documents but could not be loaded from the eCFR.

This section may have been removed, reserved, or renumbered. Browse Part 201 or Title 21 — Food and Drugs for available sections.

Nearby Sections

15

§ 201.1

Drugs; name and place of business of manufacturer, packer, or distributor.

§ 201.2

Drugs and devices; National Drug Code numbers.

§ 201.5

Drugs; adequate directions for use.

§ 201.6

Drugs; misleading statements.

§ 201.10

Drugs; statement of ingredients.

§ 201.15

Drugs; prominence of required label statements.

§ 201.16

Drugs; Spanish-language version of certain required statements.

§ 201.17

Drugs; location of expiration date.

§ 201.18

Drugs; significance of control numbers.

§ 201.19

Drugs; use of term “infant”.

§ 201.20

Declaration of presence of FD&C Yellow No. 5 and/or FD&C Yellow No. 6 in certain drugs for human use.

§ 201.21

Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use.

§ 201.22

Prescription drugs containing sulfites; required warning statements.

§ 201.23

Required pediatric studies.

§ 201.24

Labeling for systemic antibacterial drug products.